OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Risk score = LncRNAs associated with doxorubicin metabolism can be used as molecular markers for immune microenvironment and immunotherapy in non-small cell lung cancer
Qianyi Lin, Ming Zhang, Ying Kong, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e13811-e13811
Open Access | Times Cited: 12
Qianyi Lin, Ming Zhang, Ying Kong, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e13811-e13811
Open Access | Times Cited: 12
Showing 12 citing articles:
Graphene therapy-related lncRNAs as prognostic and immune microenvironmental biomarkers in hepatocellular carcinoma
Weilong Ye, Hui Li, Juan Zhao, et al.
Translational Oncology (2024) Vol. 43, pp. 101915-101915
Open Access | Times Cited: 3
Weilong Ye, Hui Li, Juan Zhao, et al.
Translational Oncology (2024) Vol. 43, pp. 101915-101915
Open Access | Times Cited: 3
Comprehensive assessment of base excision repair (BER)-related lncRNAs as prognostic and functional biomarkers in lung adenocarcinoma: implications for personalized therapeutics and immunomodulation
Junzheng Zhang, Lu Song, Guanrong Li, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 19, pp. 17199-17213
Closed Access | Times Cited: 6
Junzheng Zhang, Lu Song, Guanrong Li, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 19, pp. 17199-17213
Closed Access | Times Cited: 6
Determination of doxorubicin in plasma and tissues of mice by UPLC-MS/MS and its application to pharmacokinetic study
Zhilin Jin, Xue Xiao, Lili Gui, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35123-e35123
Open Access | Times Cited: 1
Zhilin Jin, Xue Xiao, Lili Gui, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35123-e35123
Open Access | Times Cited: 1
Combination of transcriptome and Mendelian inheritance reveals novel prognostic biomarker of CTLA-4-related lncRNAs and protective role of nitrogen metabolism pathway in lung adenocarcinoma development
Huisi Shan, Xiaocong Wang, Fei Yin, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Huisi Shan, Xiaocong Wang, Fei Yin, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
A ferroptosis‐related LncRNAs signature for predicting prognoses and screening potential therapeutic drugs in patients with lung adenocarcinoma: A retrospective study
Jiaxin Dong, Tao Tao, Jiaao Yu, et al.
Cancer Reports (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Jiaxin Dong, Tao Tao, Jiaao Yu, et al.
Cancer Reports (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Systematic analysis of transcriptome signature for improving outcomes in lung adenocarcinoma
Xiaoyong Ge, Hui Xu, Siyuan Weng, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 8951-8968
Closed Access | Times Cited: 2
Xiaoyong Ge, Hui Xu, Siyuan Weng, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 8951-8968
Closed Access | Times Cited: 2
Computational identification of long non-coding RNAs associated with graphene therapy in glioblastoma multiforme
Zhuoheng Zou, Ming Zhang, Shang Zhong Xu, et al.
Brain Communications (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 2
Zhuoheng Zou, Ming Zhang, Shang Zhong Xu, et al.
Brain Communications (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 2
Identification and Functional Characterization of PI3K/Akt/mTOR Pathway-Related lncRNAs in Lung Adenocarcinoma: A Retrospective Study.
Jiaqi Zhong, Ying Kong, Ruming Li, et al.
PubMed (2024) Vol. 26, Iss. 1, pp. 13-27
Closed Access
Jiaqi Zhong, Ying Kong, Ruming Li, et al.
PubMed (2024) Vol. 26, Iss. 1, pp. 13-27
Closed Access
Predicting pan-cancer immune-checkpoint therapy and prognosis with a chromatin-accessibility-related alternative splicing signature: a retrospective study
Yitong Li, Feifei Lan, Yi‐Ling Lin, et al.
International Journal of Surgery Oncology (2024)
Open Access
Yitong Li, Feifei Lan, Yi‐Ling Lin, et al.
International Journal of Surgery Oncology (2024)
Open Access
Development and application of a predictive model for survival and drug therapy based on COVID-19-related lncRNAs in non-small cell lung cancer
Ziyuan Huang, Zenglei Han, Kairong Zheng, et al.
Medicine (2024) Vol. 103, Iss. 49, pp. e40629-e40629
Open Access
Ziyuan Huang, Zenglei Han, Kairong Zheng, et al.
Medicine (2024) Vol. 103, Iss. 49, pp. e40629-e40629
Open Access
A lncRNA-disease association prediction model based on the two-step PU learning and fully connected neural networks
Hou Biyu, Tan Guangwen, Ming Zeng, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e17726-e17726
Open Access | Times Cited: 1
Hou Biyu, Tan Guangwen, Ming Zeng, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e17726-e17726
Open Access | Times Cited: 1
Editorial: Epigenetics in cancer: mechanisms and drug development-volume II
Xiao Zhu, Zhenhua Xu, Yaqin Li
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1
Xiao Zhu, Zhenhua Xu, Yaqin Li
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1
